PRESCRIBING · PART D · 2024
Total Rx claims
75
Beneficiaries
—
Total drug cost
$100K
Distinct drugs
4
Brand share
56.0%
Top prescribed drugs
Rimegepant Sulfate22 claims
Fremanezumab-Vfrm20 claims
Levetiracetam17 claims
Amitriptyline Hcl16 claims
QUALITY · MIPS · 2024
Final MIPS score
79.0
Quality
62.4
Cost
72.7
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.17%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CROSS-REFERENCE